methyl (4Z)-1-ethyl-4-[(2-hydroxynaphthalen-1-yl)methylidene]-2-methyl-5-oxopyrrole-3-carboxylate

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: methyl (4Z)-1-ethyl-4-[(2-hydroxynaphthalen-1-yl)methylidene]-2-methyl-5-oxopyrrole-3-carboxylate
• 化学式: C₂₀H₁₉NO₄
• 分子量: 337.4
• InChiKey: QVJDJKAINBFXSG-WJDWOHSUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  66.8
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• METHOD OF TREATING CANCER WITH MODULATORS OF SCFSkp2
  申请人：Cardozo Timothy

  公开号：US20140142120A1

  公开（公告）日：2014-05-22

  The present invention relates to pharmaceutical compositions comprising a compound and a pharmaceutically acceptable carrier. The present invention is also directed to a method of treating cancer in a subject. Also disclosed are methods of inhibiting SCF-Skp2 activity and a method of identifying inhibitors of SCF-Skp2 activity.
• US9261497B2
  申请人：——

  公开号：US9261497B2

  公开（公告）日：2016-02-16
• [EN] METHOD OF TREATING CANCER WITH MODULATORS OF SCFSkp2<br/>[FR] MÉTHODE DE TRAITEMENT DU CANCER AVEC DES MODULATEURS DE L'ACTIVITÉ DU COMPLEXE SCF-SKP2
  申请人：UNIV NEW YORK

  公开号：WO2014062811A2

  公开（公告）日：2014-04-24

  The present invention relates to pharmaceutical compositions comprising a compound and a pharmaceutically acceptable carrier. The present invention is also directed to a method of treating cancer in a subject. Also disclosed are methods of inhibiting SCF-Skp2 activity and a method of identifying inhibitors of SCF-Skp2 activity.